These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906 [TBL] [Abstract][Full Text] [Related]
43. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor. Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115 [TBL] [Abstract][Full Text] [Related]
44. Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator. Niessen F; Hilger T; Hoehn M; Hossmann KA Stroke; 2002 Dec; 33(12):2999-3005. PubMed ID: 12468803 [TBL] [Abstract][Full Text] [Related]
45. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury. Wang CX; Ding X; Shuaib A Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697 [TBL] [Abstract][Full Text] [Related]
47. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction. Anand S; Diamond SL Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700 [TBL] [Abstract][Full Text] [Related]
48. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots. Meunier JM; Holland CK; Pancioli AM; Lindsell CJ; Shaw GJ Thromb Res; 2009; 123(3):528-36. PubMed ID: 18619651 [TBL] [Abstract][Full Text] [Related]
49. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation. Hare TR; Gardell SJ Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162 [TBL] [Abstract][Full Text] [Related]
50. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution. Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468 [TBL] [Abstract][Full Text] [Related]
51. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats. Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603 [TBL] [Abstract][Full Text] [Related]
52. Enhanced clot lysis by a single point mutation in a reteplase variant. Chen S; Chen D; Liu Y; Xu Y; Lin H; Cheng Y; Li J; Meng C; Liang M; Yuan C; Huang M Br J Haematol; 2022 Feb; 196(4):1076-1085. PubMed ID: 34783361 [TBL] [Abstract][Full Text] [Related]
53. Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo. Dewerchin M; Lijnen HR; Stassen JM; De Cock F; Quertermous T; Ginsberg MH; Plow EF; Collen D Blood; 1991 Aug; 78(4):1005-18. PubMed ID: 1831057 [TBL] [Abstract][Full Text] [Related]
54. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke. Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979 [TBL] [Abstract][Full Text] [Related]